Epizyme proposes IPO

Cancer company Epizyme Inc. (Cambridge, Mass.) proposed to raise up to $69 million in an IPO underwritten by Citi; Cowen; Leerink; JMP Securities; and Wedbush PacGrow. Epizyme's lead candidate, EPZ-56...